Search
Search filters
Type
Audience
Category
Issue
Last updated
- 2024736 results available
- 20231810 results available
- 20221404 results available
- 20211150 results available
- 2020773 results available
- 20191016 results available
- 2018854 results available
- 2017627 results available
- 2016605 results available
- 2015371 results available
- 2014385 results available
- 2013478 results available
- 2012398 results available
- 2011731 results available
Recall class
Displaying 1 - 15 of 11347 items.
Zyn Nicotine Pouches: Product sold without market authorization (NPN in Canada)
RecallHealth product recall | 2024-06-12
Various Super Lube Products by Kano Laboratories recalled due to lack of labelling information and child-resistant packaging
RecallConsumer product recall | 2024-06-10
Wild Country Ropeman 1 Ascenders recalled due to potential physical hazard
RecallConsumer product recall | 2024-06-10
Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
RecallHealth product recall | 2024-06-10
PMS-PIRFENIDONE 267 & 801 mg: Data integrity concerns with products bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-07
MiO Energy brand Energy Drink Mixes recalled due to potentially unsafe levels of caffeine
RecallFood recall warning | 2024-06-07
Transport Canada Recall - 2024298 - TESLA
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024300 - WINNEBAGO INDUSTRIES
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024301 - KARMA
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024304 - TOYOTA
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024305 - HONDA
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024306 - FOREST RIVER
RecallAutomotive recall | 2024-06-07
Transport Canada Recall - 2024309 - NISSAN
RecallAutomotive recall | 2024-06-07
Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06
Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06